www.bostonpharmasupport.com Open in urlscan Pro
35.209.75.118  Public Scan

Form analysis
0 forms found in the DOM

Text Content

Skip to content
 * Home
 * Business
   * Boston Market Review (2017)
   * Business Development Portal
   * CRO & CDMO Reports
   * CRM Portal
 * Science
   * Process Technology Portfolio
 * Quality
   * Pharmaceutical Quality/CMC – Guidances
   * CMC Development Strategies for Small Pharma
   * The Role of CMC In Early Trials
 * Clients
 * Contact

 * Boston Pharmaceutical Support ®
   Click to scroll
   POWER OF COLLECTIVE AMBITION
 * Synthetic Chemistry & API's
   Click to scroll
 * Process Development & Scale-up
   Click to scroll
 * Pharmaceutical Quality & CMC
   Click to scroll
 * Business Development for CRO & CDMO's 
   Click to scroll
 * Customer Relationship Management (CRM)
   Click to scroll






OUR KEY SERVICES


BUSINESS

Business Development, Outsourcing , Training, CRM

 

Business Development support within the Boston region to CRO’s & CDMO’s  to
collaborate on scientific projects that are a genuine fit for all stakeholders.

High-level facilitation of introductions and presentation of pipeline assets
with licensing partners in EU & USA.

Training for CRO & CDMO Business Development staff including private coaching.

Development, hosting and implementation of Customer Relationship Management
(CRM) systems.


SCIENCE

Discovery Support, Process R&D, API Manufacturing

 

Supporting pharmaceutical and biotec companies in New England throughout the
drug R&D process.

Expert analysis, evaluation and selection of Contract Research, Development and
Manufacturing (CRO & CDMO) partners to optimize outsourcing solutions.

Scientific & operational reviews, references and case studies from CRO & CDMO’s.

We have a demonstrated track record of shortening pipeline development time
while maintaining quality and integrity.

 


CONSULTANCY

Pipeline Acceleration, Outsourcing Efficiency, 

Business Development, CRM

Personalized service combining our Worldwide experience of API chemistry & the
pharmaceutical R&D business.

Synthetic chemistry, API’s, Process Development, Scale-up & integrated services
management, Business Development & Customer Relationship Management (CRM)
systems are our core competency with 30 years expertise.

Identification & support of Subject Matter Experts (SMEx) in the field of
Medicinal Chemistry, Drug Development, Pharmaceutical Quality & CMC.

this is how we help your company


HOW WE HELP YOUR COMPANY


BUSINESS DEVELOPMENT

• Representation for CRO’s & CDMO’s • Sales & Business Management • Sales
Process Engineering • Pipeline Analysis & Evaluation • Sales Team Training &
Coaching •

• Licensing Deals with EU & US Pharma • Strategic Partnering • Technology
Scouting • Analytics • Deal Negotiation •

 


CUSTOMER RELATIONSHIP MANAGEMENT (CRM)

• Prospect • Win • Retain • Repeat •

• CRM Development • Implementation • Sales-force automation • Hosting •

• Campaigns • Collaboration • Mobile CRM • Social CRM • Reporting •

• Manage interactions • Manage data from multiple communication channels:
company’s website, phone, email, marketing materials & social media • Analyze
history • Improve business relationships • Focus on acquisition of new customers
• Drive sales growth •

 


OUTSOURCING

• Project Evaluation • Outsourcing Strategy • CRO & CDMO Provider Evaluation &
Reports • Partner Selection • Integration with internal resources • Expert
analysis •

 


PIPELINE PROGRESS, ACCELERATION & DELIVERABLES

• Strategy for Outsourcing Management • pre-clinical & clinical materials
acquisition • Timeline Compression • Process Scale-up and cGMP Materials
security and delivery •

 


PHARMACEUTICAL QUALITY & CHEMISTRY AND MANUFACTURING CONTROLS (CMC)

• Early Development Consultancy • Subject Matter Experts • NDA, ANDA Support •
DMF Support • Environmental Assessment • INDs for Phase 2 and Phase 3 Studies •
IND Meetings • NDAs: Impurities in Drug Substances • Residual Solvents •
Analytical Procedures & Methods Validation • Documentation Submission for Drug
Products •

 




BUSINESS & STAFF TIMELINE


FOUNDED

August 2010

Amalgamated 20+ years Synthetic Chemistry R&D, Scale-up, API & Intermediates
manufacturing experience, WITH 15 years of Business Management in Sales,
Marketing, collaborative deals and project management, TOGETHER with a
formidable toolbox of chemical & process technology, INCLUDING unusual process
specialities such as loop reactor, static flow, vapor phase & continuous
reactions, SERVING commercial relationships to more than 500 western drug
companies.




INDIA & WORD HEALTH ORGANIZATION COLLABORATION

2011

Supported lead-in drug development and cost reduction activities for the WHO
Global Malaria Programme. This has since become responsible for coordinating
WHO’s global efforts to control and eliminate malaria. The work formed part of
guidance by the Global Technical Strategy for Malaria 2016–2030 (GTS) adopted by
the World Health Assembly in May 2015.


PLUG-IN TO CHINA INTRODUCED.

2012

Our experience, packaged into a “guidance” service to provide support for
companies interested in working with Chinese CDMO’s. Whether to use China or
stay domestic is the important decision that we support. Our team have helped
hundreds of companies in the USA & Europe transition into a collaboration with
China-based CRO/CMDO’s. It can be exceptionally beneficial, but daunting &
risky. It is not necessarily the right choice, so let us guide you.




BOSTON & CAMBRIDGE FOCUS & HQ

2015

It was a perfect match to center our support work in Boston and headquarter our
business: Boston Biotech focuses on Drug Discovery & Development, and so do we.
Over 1500 drug candidates in the pipelines of hundreds of small start-ups,
executed by more than 30,000 R&D jobs, alongside established
pharmaceutical incubators & world class research institutions is a collaborative
ecosystem in which we decided to specialize amongst.


10TH PHARMA CLIENT

January 2017

The number of Clients we served, by supporting their R&D outsourcing activities
reached double-digits.




PROSPECT, WIN, RETAIN, REPEAT LAUNCH

March 2017

Our Customer Relationship Management (CRM) service designed specifically for
CRO’s and CDMO’s in the pharma- R&D space. In a cost-effective manner, from
pre-design strategy to post-deployment training, our CRM solutions deliver the
functionality users expect and the flexibility a business needs to adapt and
grow.


OUR 7 YEAR BIRTHDAY

August 2017



DO YOU WANT TO…




TAKE SOME TIME AND MEET OUR EMPLOYEES?

Meet the team


...OR MAYBE SEE SOME FACTS ABOUT US?

See some facts



OUR TEAM

Philibert Audebrand
Business Development

Philibert Audebrand
Business Development
Wompiano Young
Administration

Wompiano Young
Administration
Mario Uchard
Organic Chemist

Mario Uchard
Organic Chemist
John Stevens
Accountant

John Stevens
Accountant
Young Man
Regulatory Affairs

Young Man
Regulatory Affairs
Hunter Weiner
Developer

Hunter Weiner
Developer

CRO's & CDMO's
28
Technical Research Projects
122
Development Projects
292
NCE's
320


WHAT OUR CLIENTS SAY

> … we had critical milestones to reach and of course time was pressing. Our API
> synthesis was long and unoptimized. One day beyond the deadline could have
> cost our company another year in development. Their expericence is so well
> balanced with their focus on our goals, that they were successfully able to
> meet our needs by comprehension of the project’s intimately interconnected
> parts by reference to the whole …


Robert C. Cheif Scientific Officer, Fast Emerging BioPharma.

> … successful in closing the deal due to their attention to detail, prompt
> replies to our queries and excellent communication. They were attentive to our
> needs throughout the duration of the contract which resulted in a level of
> confidence …


Jan S. VP CMC, Emerging Pharmaceutical Company

> … our sales team were losing opportunities to the competition and we couldn’t
> figure out why. Without saturating us with jargon and new processes BPS
> started to change the way we talked to our prospects. Six months later  they
> transformed the way that we present our capabilities and proposals to our
> Clients …


Paul S. Chief Commercial Officer, CDMO

> … BPS training on their customized CRM platform was so simple that our field
> sales team immediately embraced it. We saw immediate benefits while previous
> initiatives were met with such resistance …

Julie S. Sales Support Director.

> … the company immediately grasped the nature of our business and culture. I’m
> not sure if it was their experience or background research, but we were able
> to hold meaningful discussions from the outset without having educate them on
> what we needed …

John D. Chief Technical Officer, Small Pharmaceutical Company




OUR WORK

 * Show all
 * Business
 * Consultancy
 * Science

API Outsourcing Scale-up Support
Business Development Representation


WHO WE ARE:

We are a Boston-based company specializing in the CONFIDENTIAL execution of
projects that support the Business and Technical Development of New Chemical
Entities (NCE's) intended to provide important new therapies for patients.

 * Ethical approach to our Clients Intellectual Property AND Funds.
 * Extensive technical experience in chemical development for Pharmaceutical
   API's.
 * Deep successful International experience with the CRO's and CDMO's.
 * Skills that recognize the importance of decisions made implementing IND
   projects.
 * Success in USA, Europe, China and India has underpinned our success in
   shortening timelines.


WHAT WE DO:

Business Development & Sales
58%

Customer Relationship Management (CRM)
25%

Technical & Development
10%

Technology & Products
7%



WANT TO KNOW MORE ABOUT OUR COMPANY? CURIOUS WHAT ELSE WE DO?

LEARN


ABOUT US

You’ve reached the right place to acquire professional research, development &
Pharmaceutical Quality/CMC support services.

Whether you want full-time project-specific support for several months, or just
a couple of hours on a specific task, our flexible model allows or Clients to
tap into an extensive network of innovators, technical experts, and seasoned
professionals.

Intellectual Property (IP) is the most valuable asset in your Company. Awareness
& security of our Clients IP is at the heart of our business: we’ll not only
protect the value of our Clients assets through traceable Confidentiality
Agreements and written Protocols, but we have a proven track record of enhancing
the quality and value of this IP while our Clients maintain 100% of the
developed IP when using Boston Pharmaceutical Support Services.

During the recruitment of our specialists we search for professionals with three
core attributes that match our own at Boston Pharmaceutical Support, because our
Clients will never love our company unless the employees love it first:

1: Personal characteristics that match the defined ethical values & core
competencies of Boston Pharmaceutical Support.
2: Qualifications specific to the expert services that they support for our
Clients.
3: Experience as mature professionals in the Drug Discovery and Drug Development
community.

Thank You for visiting the Boston Pharmaceutical Support. Work with us soon.


POWER OF COLLECTIVE AMBITION





LATEST NEWS

SHIRE STOCK RISING ON TAKEOVER TALKS – THESTREET

Shire Stock Rising on Takeover Talks Amanda Schiavo Follow Jul 26, 2017 4:29 PM
EDT Get TheStreet Quant Ratings’ exclusive 5-page report for (SHPG) – FREE.
Shire is a biotech company that is focused on serving people with rare diseases
and other specialized conditions. Shares of Shire PLC (SHPG) were gaining by
more than 3% […]

ALEXION SPIKES ON Q2 EARNINGS BLOWOUT PROVIDING POSITIVE SIGNS FOR REST OF
SECTOR

Shares of Alexion Pharmaceuticals Inc. (ALXN) rose 6.7% to $139.88 in premarket
trading on Thursday, July 27, after the New Haven, Conn.-based firm unveiled
second-quarter results. Source: Alexion Spikes on Q2 Earnings Blowout Providing
Positive Signs for Rest of Sector -Biotech Movers – TheStreet

TETRAPHASE CLAWS BACK FROM FAILED STUDY, EYES FDA FILING WITH NEW DATA

New data have given new life to Tetraphase Pharmaceuticals (NASDAQ: TTPH), which
now has a shot to bring an experimental antibiotic to market despite a failed
trial in the past.The Watertown, MA, company reported positive results late
Tuesday in a 500-patient Phase 3 study of its lead antibiotic, eravacycline, in
patients with complicated intra-abdominal infections […]


 * Linkedin
 * Twitter
 * Facebook


LETS GET IN TOUCH



TALK WITH US

Skype:BostonPharmaSupport

COME MEET WITH US

Commercial Street,

Boston, MA 02109,

United States of America

EMAIL US AT

enquiries@bostonpharmasupport.com

SUBSCRIBE

Press !

© Boston Pharmaceutical Support 2016 • © Boston Baseline Digital Marketing 2017
• BPS Black Ops Team •